SCHEMBL7956086

SCHEMBL7956086

COC(=O)[C@@H](NC(=O)c1ccccc1OCc1ccccc1)C(C)O

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SGMS2 Q8NHU3 6/20 0.55
▸ NPC1 O15118 1/20 0.53
▸ GAA P10253 1/20 0.52
▸ CTSK P43235 1/20 0.52
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ FAAH O00519 1/20 0.50
▸ CNR1 P21554 1/20 0.50
▸ CNR2 P34972 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ PPIA P62937 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15941245 1.00 SGMS2 (0.55) SGMS2NPC1GAACTSKMEN1
SCHEMBL7956090 1.00 SGMS2 (0.55) SGMS2NPC1GAACTSKMEN1
SCHEMBL15947711 1.00 SGMS2 (0.55) SGMS2NPC1GAACTSKMEN1
SCHEMBL7723401 0.93 SGMS2 (0.55) SGMS2NPC1GAACTSKMEN1
SCHEMBL7723403 0.93 SGMS2 (0.55) SGMS2NPC1GAACTSKMEN1
SCHEMBL15941034 0.90 SGMS2 (0.58) SGMS2NPC1GAACTSKMEN1
SCHEMBL15941211 0.90 SGMS2 (0.58) SGMS2NPC1GAACTSKMEN1
SCHEMBL7761787 0.90 SGMS2 (0.58) SGMS2NPC1GAACTSKMEN1
SCHEMBL17389356 0.85 SGMS2 (0.55) SGMS2NPC1GAACTSKMEN1
SCHEMBL15947736 0.85 SGMS2 (0.55) SGMS2NPC1GAACTSKMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310058-B1 N-HYDROXYAZEPIN-2-ONES SUBSTITUTED AT 3 POSITION WITH A GROUP CONTAINING A 2-PHENYLOXAZOLE OR 2-PHENYLOXAZOLINE GROUP FOR TREATING TUBERCULOSIS UNIVERSITY OF NOTRE DAME DU LAC 2001-10-30 — — US disclosed
Send feedback